Fatal immune hemolytic anemia following allogeneic stem cell transplantation: Report of 2 cases and review of literature

Transfusion Medicine Reviews

Volumn 27, Issue 3, 2013, Pages 166-170

  Rovira, Jordina ^a   Cid, Joan ^a   Gutiérrez García, Gonzalo ^a   Pereira, Arturo ^a   Fernández Avilés, Francesc ^a   Rosiñol, Laura ^a   Martínez, Carmen ^a   Carreras, Enric ^a   Urbano, Álvaro ^a   Rovira, Montserrat ^a   Lozano, Miguel ^a  

^a INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; BORTEZOMIB; CYCLOPHOSPHAMIDE; ECULIZUMAB; HEMOGLOBIN; IMMUNOGLOBULIN; LACTATE DEHYDROGENASE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RITUXIMAB; THYMOCYTE ANTIBODY;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; BILIRUBIN BLOOD LEVEL; CASE REPORT; DRUG TREATMENT FAILURE; ERYTHROBLASTOPENIA; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; MALE; PHENOTYPE; PLASMAPHERESIS; WHOLE BODY RADIATION;

EID: 84880740818     PISSN: 08877963     EISSN: 15329496     Source Type: Journal    
DOI: 10.1016/j.tmrv.2013.02.004     Document Type: Article

References (38)

1. Petz L.D., Garratty G. Classification and clinic characteristics of autoimmune hemolytic anemias. Immune hemolytic anemias 2004, Churchill Livingstone, Philadelphia.
2. Silberstein L.E.C.M. Autoimmune hemolytic anemias. Blood banking and transfusion medicine 2006, Churchill Livingstone, Philadelphia. C.D. Hillyer (Ed.).
3. Chen F.E., Owen I., Savage D., Roberts I., Apperley J., Goldman J.M., et al. Late onset haemolysis and red cell autoimmunisation after allogeneic bone marrow transplant. Bone Marrow Transplant 1997, 19:491-495.
4. Godder K., Pati A.R., Abhyankar S.H., Lamb L.S., Armstrong W., Henslee-Downey P.J. De novo chronic graft-versus-host disease presenting as hemolytic anemia following partially mismatched related donor bone marrow transplant. Bone Marrow Transplant 1997, 19:813-817.
5. O'Brien T.A., Eastlund T., Peters C., Neglia J.P., Defor T., Ramsay N.K., et al. Autoimmune haemolytic anaemia complicating haematopoietic cell transplantation in paediatric patients: high incidence and significant mortality in unrelated donor transplants for non-malignant diseases. Br J Haematol 2004, 127:67-75.
6. Sanz J., Arriaga F., Montesinos P., Orti G., Lorenzo I., Cantero S., et al. Autoimmune hemolytic anemia following allogeneic hematopoietic stem cell transplantation in adult patients. Bone Marrow Transplant 2007, 39:555-561.
7. Bashey A., Owen I., Lucas G.F., Amphlett N.W., Jones M.M., Lawal A., et al. Late onset immune pancytopenia following bone marrow transplantation. Br J Haematol 1991, 78:268-274.
8. Radhi M., Rumelhart S., Tatman D., Goldman F. Severe autoimmune hemolytic anemia after unrelated umbilical cord blood transplant for familial hemophagocytic lymphohistiocytosis: significant improvement after treatment with rituximab. J Pediatr Hematol Oncol 2007, 29:125-127.
9. De Lord C., Marsh J.C., Smith J.G., Singer C.R., Gordon-Smith E.C. Fatal autoimmune pancytopenia following bone marrow transplantation for aplastic anaemia. Bone Marrow Transplant 1996, 18:237-239.
10. Hartert A., Willenbacher W., Gunzelmann S., Roemer E., Basara N., Fauser A.A., et al. Successful treatment of thrombocytopenia and hemolytic anemia with IvIG in a patient with lupus-like syndrome after mismatched related PBSCT. Bone Marrow Transplant 2001, 27:337-340.
11. Klumpp T.R., Caligiuri M.A., Rabinowe S.N., Soiffer R.J., Murray C., Ritz J. Autoimmune pancytopenia following allogeneic bone marrow transplantation. Bone Marrow Transplant 1990, 6:445-447.
12. Kako S., Kanda Y., Oshima K., Nishimoto N., Sato H., Watanabe T., et al. Late onset of autoimmune hemolytic anemia and pure red cell aplasia after allogeneic hematopoietic stem cell transplantation using in vivo alemtuzumab. Am J Hematol 2008, 83:247-249.
13. Sherer Y., Shoenfeld Y. Autoimmune diseases and autoimmunity post-bone marrow transplantation. Bone Marrow Transplant 1998, 22:873-881.
14. Daikeler T., Tyndall A. Autoimmunity following haematopoietic stem-cell transplantation. Best Pract Res Clin Haematol 2007, 20:349-360.
15. Drobyski W.R., Potluri J., Sauer D., Gottschall J.L. Autoimmune hemolytic anemia following T cell-depleted allogeneic bone marrow transplantation. Bone Marrow Transplant 1996, 17:1093-1099.
16. Holbro A., Abinun M., Daikeler T. Management of autoimmune diseases after haematopoietic stem cell transplantation. Br J Haematol 2012, 157:281-290.
17. Loh Y., Oyama Y., Statkute L., Quigley K., Yaung K., Gonda E., et al. Development of a secondary autoimmune disorder after hematopoietic stem cell transplantation for autoimmune diseases: role of conditioning regimen used. Blood 2007, 109:2643-3548.
18. Sevilla J., Gonzalez-Vicent M., Madero L., Diaz M.A. Acute autoimmune hemolytic anemia following unrelated cord blood transplantation as an early manifestation of chronic graft-versus-host disease. Bone Marrow Transplant 2001, 28:89-92.
19. Sokol R.J., Stamps R., Booker D.J., Scott F.M., Laidlaw S.T., Vandenberghe E.A., et al. Posttransplant immune-mediated hemolysis. Transfusion 2002, 42:198-204.
20. Cwynarski K., Goulding R., Pocock C., Dazzi F., Craddock C., Kaeda J., et al. Immune haemolytic anaemia following T cell-depleted allogeneic bone marrow transplantation for chronic myeloid leukaemia: association with leukaemic relapse and treatment with donor lymphocyte infusions. Bone Marrow Transplant 2001, 28:581-586.
21. Sokal E., Michel M., Ninane J., Latinne D., De Bruyere M., Cornu G. Bone marrow transplantation from an unrelated donor for Fanconi's anaemia: two unusual complications. Bone Marrow Transplant 1987, 2:99-102.
22. Tamura T., Kanamori H., Yamazaki E., Ohtsuka M., Hataoka K., Maeda K., et al. Cold agglutinin disease following allogeneic bone marrow transplantation. Bone Marrow Transplant 1994, 13:321-323.
23. Horn B., Viele M., Mentzer W., Mogck N., Desantes K., Cowan M. Autoimmune hemolytic anemia in patients with SCID after T cell-depleted BM and PBSC transplantation. Bone Marrow Transplant 1999, 24:1009-1013.
24. Mullen C.A., Thompson J.N., Richard L.A., Chan K.W. Unrelated umbilical cord blood transplantation in infancy for mucopolysaccharidosis type IIB (Hunter syndrome) complicated by autoimmune hemolytic anemia. Bone Marrow Transplant 2000, 25:1093-1097.
25. Au W.Y., Lie A.K., Liang R., Lam C.C., Kwong Y.L. Fulminant late onset cold hemagglutinin disease after allogeneic bone marrow transplantation. Haematologica 2000, 85:E10.
26. Pratt G., Kinsey S.E. Remission of severe, intractable autoimmune haemolytic anaemia following matched unrelated donor transplantation. Bone Marrow Transplant 2001, 28:791-793.
27. Hongeng S., Tardtong P., Worapongpaiboon S., Ungkanont A., Jootar S. Successful treatment of refractory autoimmune haemolytic anaemia in a post-unrelated bone marrow transplant paediatric patient with rituximab. Bone Marrow Transplant 2002, 29:871-872.
28. Ship A., May W., Lucas K. Anti-CD20 monoclonal antibody therapy for autoimmune hemolytic anemia following T cell-depleted, haplo-identical stem cell transplantation. Bone Marrow Transplant 2002, 29:365-366.
29. Corti P., Bonanomi S., Vallinoto C., Balduzzi A., Uderzo C., Cazzaniga G., et al. Rituximab for immune hemolytic anemia following T- and B-cell-depleted hematopoietic stem cell transplantation. Acta Haematol 2003, 109:43-45.
30. Raj K., Narayanan S., Augustson B., Ho A., Mehta P., Duncan N., et al. Rituximab is effective in the management of refractory autoimmune cytopenias occurring after allogeneic stem cell transplantation. Bone Marrow Transplant 2005, 35:299-301.
31. Chen R.L., Wu P.L., Hsu Y.H., Kuo P.L. Evans syndrome after unrelated cord blood transplantation for disseminated Langerhans cell histiocytosis in a child. J Pediatr Hematol Oncol 2007, 29:348-350.
32. Chao M.M., Levine J.E., Ferrara J.L., Cooling L., Cooke K.R., Hutchinson R.J., et al. Successful treatment of refractory immune hemolysis following unrelated cord blood transplant with Campath-1H. Pediatr Blood Cancer 2008, 50:917-919.
33. Page K.M., Mendizabal A.M., Prasad V.K., Martin P.L., Parikh S., Wood S., et al. Posttransplant autoimmune hemolytic anemia and other autoimmune cytopenias are increased in very young infants undergoing unrelated donor umbilical cord blood transplantation. Biol Blood Marrow Transplant 2008, 14:1108-1117.
34. Rokicka M., Styczynski J., Michalewska B., Torosian T., Tomaszewska A., Gronkowska A., et al. Fatal combined immune hemolytic anemia after double cord blood transplantation in imatinib-resistant CML. Bone Marrow Transplant 2009, 44:383-385.
35. Dahl D., Hahn A., Koenecke C., Heuft H.G., Dammann E., Stadler M., et al. Prolonged isolated red blood cell transfusion requirement after allogeneic blood stem cell transplantation: identification of patients at risk. Transfusion 2010, 50:649-655.
36. Jung S.H., Ahn J.S., Yang D.H., Chul Park H., Bae S.Y., Kim Y.K., et al. Successful treatment of pure red cell aplasia with rituximab in patients after ABO-compatible allogeneic hematopoietic stem cell transplantation. Case Rep Oncol 2012, 5:110-113.
37. Helbig G., Stella-Holowiecka B., Wojnar J., Krawczyk M., Krzemien S., Wojciechowska-Sadus M., et al. Pure red-cell aplasia following major and bi-directional ABO-incompatible allogeneic stem-cell transplantation: recovery of donor-derived erythropoiesis after long-term treatment using different therapeutic strategies. Ann Hematol 2007, 86:677-683.
38. Vaughan J.I., Manning M., Warwick R.M., Letsky E.A., Murray N.A., Roberts I.A. Inhibition of erythroid progenitor cells by anti-Kell antibodies in fetal alloimmune anemia. N Engl J Med 1998, 338:798-803.